Pluri Inc.
A biotechnology company in Haifa, Israel, that grows human, animal, and plant cells at industrial scale using a three-dimensional cell-expansion platform. Its placenta-derived PLX cell therapies target inflammatory and muscle conditions, while the same technology also feeds cultivated-meat and agricultural projects. Founded from stem-cell patents developed during founder Shai Meretzki's PhD at the Technion, it was long known as Pluristem Therapeutics before shortening its name to Pluri in 2022 — a nod to "pluripotent" cells.
Bought 2.40M
Granted 2.26M · Bought 1.43M
Granted 190.3K
Bought 1.57M · Sold 955.7K
Granted 850.0K · Bought 187.8K · Sold 239.3K
Granted 836.0K · Sold 202.2K
Granted 586.2K
Granted 420.0K
Granted 6.57M · Bought 4.16M · Sold 141.9K
Granted 209.7K
Granted 6.06M · Bought 319.4K · Sold 185.9K
Granted 75.8K · Bought 4.7K
Granted 71.5K
Granted 606.2K · Bought 50.0K
Granted 826.5K · Sold 180.8K
Granted 563.4K
Granted 377.5K · Bought 28.6K · Sold 12.5K
Granted 927.5K · Bought 33.6K · Sold 12.3K
Granted 36.8K
Granted 20.0K
Granted 71.6K
Granted 70.0K
Granted 68.9K
Granted 12.4K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Doyle Michael C. +1 co-filer10% owner · 2 transactions | — | 100.00Mas of Aug 2007 | — | — | — |
| Meretski Shai10% owner · 1 transaction | — | 4.80Mas of Jan 2006 | — | 2.40M | — |
| Chutzpah Holdings Ltd +1 co-filer10% owner, Director, 10% owner · 10 transactions | — | 4.78M | 2.26M | 1.43M | — |
| Manieu Alexandre WeinsteinDirector, 10% owner · 2 transactions | — | 3.83M | 190.3K | — | — |
| Clover Wolf Capital - Limited Partnership10% owner · 41 transactions | — | 3.17Mas of May 2021 | — | 1.57M | 955.7K |
| Ben-Yoram IsraelDirector · 47 transactions | — | 798.5Kas of Apr 2019 | 850.0K | 187.8K | 239.3K |
| Rosman NachumDirector · 21 transactions | — | 633.7Kas of Dec 2018 | 836.0K | — | 202.2K |
| Meretzki HavaDirector · 16 transactions | — | 586.2Kas of Dec 2018 | 586.2K | — | — |
| Egozi ErezChief Financial Officer · 5 transactions | — | 518.0Kas of Dec 2018 | 420.0K | — | — |
| Yanay YakyChief Executive Officer, Director · 50 transactions | — | 498.6K | 6.57M | 4.16M | 141.9K |
| Pines ShaiDirector · 7 transactions | — | 209.7Kas of Dec 2011 | 209.7K | — | — |
| Aberman ZamiDirector · 50 transactions | — | 155.7K | 6.06M | 319.4K | 185.9K |
| Gur-Lavie BoazChief Financial Officer · 4 transactions | — | 107.6Kas of Jan 2015 | 75.8K | 4.7K | — |
| Zalts LiatChief Financial Officer · 2 transactions | — | 92.8K | 71.5K | — | — |
| Braun IsaacDirector · 18 transactions | — | 83.6Kas of Sep 2020 | 606.2K | 50.0K | — |
| Germain MarkDirector · 25 transactions | — | 82.6Kas of Sep 2020 | 826.5K | — | 180.8K |
| Franco-Yehuda ChenChief Financial Officer · 5 transactions | — | 67.5Kas of Sep 2024 | 563.4K | — | — |
| Kwiat MoriaDirector · 12 transactions | — | 57.4Kas of Sep 2020 | 377.5K | 28.6K | 12.5K |
| Shorrer DoronDirector · 22 transactions | — | 45.2K | 927.5K | 33.6K | 12.3K |
| Abony Lorne KennethDirector · 1 transaction | — | 36.8Kas of Jan 2024 | 36.8K | — | — |
| Shalev VardaDirector · 1 transaction | — | 20.0Kas of Jul 2021 | 20.0K | — | — |
| Birger Pinhas DoronDirector · 3 transactions | — | 19.2Kas of Feb 2025 | 71.6K | — | — |
| Shemesh-Rasmussen MaitalDirector · 4 transactions | — | 19.1K | 70.0K | — | — |
| Levi Rami AvrahamDirector · 4 transactions | — | 19.0K | 68.9K | — | — |
| Ajchenbaum EitanDirector · 2 transactions | — | 12.4K | 12.4K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: +8.25M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.